APOD (apolipoprotein D) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: APOD (apolipoprotein D) Homo sapiens
Analyze
Symbol: APOD
Name: apolipoprotein D
RGD ID: 737460
HGNC Page HGNC:612
Description: Enables cholesterol binding activity. Involved in several processes, including negative regulation of cell-matrix adhesion; negative regulation of macromolecule metabolic process; and negative regulation of protein import into nucleus. Located in extracellular space and perinuclear region of cytoplasm. Implicated in obesity and type 2 diabetes mellitus. Biomarker of Alzheimer's disease; gestational diabetes; and type 2 diabetes mellitus.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: apo-D
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Allele / Splice: See ClinVar data
Candidate Gene For: BW262_H
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh383195,568,705 - 195,583,940 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl3195,568,705 - 195,584,033 (-)EnsemblGRCh38hg38GRCh38
GRCh373195,295,576 - 195,310,811 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 363196,776,865 - 196,792,278 (-)NCBINCBI36Build 36hg18NCBI36
Celera3193,705,274 - 193,720,781 (-)NCBICelera
Cytogenetic Map3q29NCBI
HuRef3192,666,066 - 192,681,572 (-)NCBIHuRef
CHM1_13195,258,489 - 195,273,995 (-)NCBICHM1_1
T2T-CHM13v2.03198,275,776 - 198,291,015 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(-)-demecolcine  (EXP)
1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',5,5'-tetrachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (ISO)
2,3-bis(4-hydroxyphenyl)propionitrile  (EXP)
2,4,4'-trichlorobiphenyl  (ISO)
2-acetamidofluorene  (ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (EXP)
3-methyladenine  (EXP)
3-methylcholanthrene  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxynon-2-enal  (ISO)
4-hydroxyphenyl retinamide  (ISO)
5-aza-2'-deoxycytidine  (EXP)
6-propyl-2-thiouracil  (ISO)
8-anilinonaphthalene-1-sulfonic acid  (EXP)
acrylamide  (EXP)
actinomycin D  (EXP)
afimoxifene  (EXP)
aflatoxin B1  (EXP)
Aflatoxin B2 alpha  (EXP)
alachlor  (ISO)
all-trans-4-oxoretinoic acid  (EXP)
all-trans-retinoic acid  (EXP)
all-trans-retinol  (EXP)
alpha-Zearalanol  (ISO)
amitrole  (ISO)
ammonium chloride  (ISO)
anthra[1,9-cd]pyrazol-6(2H)-one  (EXP)
atrazine  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[e]pyrene  (EXP)
bexarotene  (ISO)
bisphenol A  (EXP,ISO)
bisphenol AF  (EXP)
bisphenol F  (ISO)
cadmium atom  (EXP)
cadmium dichloride  (EXP,ISO)
camptothecin  (EXP)
carbon nanotube  (ISO)
celecoxib  (EXP)
chloroquine  (EXP)
cisplatin  (EXP)
clozapine  (ISO)
copper atom  (EXP)
copper(0)  (EXP)
coumestrol  (EXP)
Cuprizon  (ISO)
DAUDA  (EXP)
dexamethasone  (EXP)
dibenz[a,h]anthracene  (ISO)
dibutyl phthalate  (ISO)
dichlorine  (ISO)
dioxygen  (EXP)
diquat  (ISO)
diuron  (ISO)
doxorubicin  (EXP,ISO)
fenvalerate  (ISO)
flavonoids  (ISO)
flurbiprofen  (ISO)
folic acid  (ISO)
formaldehyde  (EXP)
fulvestrant  (EXP)
furan  (ISO)
genistein  (EXP,ISO)
haloperidol  (ISO)
indometacin  (EXP)
isoprenaline  (ISO)
medroxyprogesterone acetate  (EXP)
methamphetamine  (ISO)
methapyrilene  (EXP)
methimazole  (ISO)
methotrexate  (ISO)
methylseleninic acid  (EXP)
monosodium L-glutamate  (ISO)
naphthalene  (ISO)
nickel atom  (EXP)
nitrofen  (ISO)
Nutlin-3  (EXP)
ospemifene  (EXP)
oxidopamine  (EXP)
ozone  (ISO)
paclitaxel  (EXP)
paraquat  (EXP,ISO)
PCB138  (ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorooctanoic acid  (ISO)
phencyclidine  (ISO)
progesterone  (EXP)
propanal  (EXP)
raloxifene  (EXP)
S-nitrosoglutathione  (EXP)
silicon dioxide  (EXP)
sirolimus  (EXP)
tamoxifen  (EXP)
testosterone  (ISO)
thyroxine  (ISO)
trichloroethene  (ISO)
trichostatin A  (EXP)
trimellitic anhydride  (ISO)
triptonide  (ISO)
troglitazone  (ISO)
valproic acid  (EXP,ISO)
vincristine  (EXP)
vinyl carbamate  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function

References

References - curated
# Reference Title Reference Citation
1. Apolipoprotein D gene polymorphism: a new genetic marker for type 2 diabetic subjects in Nauru and south India. Baker WA, etal., Diabet Med. 1994 Dec;11(10):947-52.
2. Increased expression of apolipoprotein D following experimental traumatic brain injury. Franz G, etal., J Neurochem. 1999 Oct;73(4):1615-25.
3. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
4. Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes. Hansen L, etal., Biochem Biophys Res Commun. 2004 Oct 15;323(2):685-95.
5. Factors affecting the lipid and apolipoprotein levels of cord sera. Lane DM and McConathy WJ, Pediatr Res. 1983 Feb;17(2):83-91.
6. Gene expression profiling of an arteriogenic impotence model. Lin CS, etal., Biochem Biophys Res Commun. 2001 Jul 13;285(2):565-9.
7. Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity. Montpied P, etal., Epilepsy Res. 1999 Jun;35(2):135-46.
8. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
9. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
10. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. Rickhag M, etal., J Cereb Blood Flow Metab. 2008 Mar;28(3):551-62. Epub 2007 Sep 12.
11. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. Terrisse L, etal., J Neurochem. 1998 Oct;71(4):1643-50.
12. Apolipoprotein-D polymorphism: a genetic marker for obesity and hyperinsulinemia. Vijayaraghavan S, etal., J Clin Endocrinol Metab. 1994 Aug;79(2):568-70.
Additional References at PubMed
PMID:56198   PMID:2083249   PMID:2244881   PMID:2439269   PMID:2891117   PMID:3104518   PMID:3453108   PMID:6774335   PMID:7613477   PMID:7918467   PMID:8549691   PMID:8692868  
PMID:8889548   PMID:9278274   PMID:10391209   PMID:11058760   PMID:11344130   PMID:11744388   PMID:12052480   PMID:12363390   PMID:12477932   PMID:12497622   PMID:12837283   PMID:12873803  
PMID:14500696   PMID:14551159   PMID:14596852   PMID:14718574   PMID:14760718   PMID:15192024   PMID:15316799   PMID:15489334   PMID:15862967   PMID:15916898   PMID:16169070   PMID:16335952  
PMID:16344560   PMID:16402085   PMID:16437381   PMID:16502470   PMID:16966838   PMID:17353931   PMID:17601350   PMID:17885669   PMID:18330697   PMID:18419796   PMID:18458334   PMID:18671953  
PMID:18842892   PMID:18977241   PMID:18979643   PMID:19056867   PMID:19176353   PMID:19330472   PMID:19519777   PMID:19723339   PMID:19878569   PMID:19913121   PMID:19944460   PMID:20023409  
PMID:20430392   PMID:20493910   PMID:20551380   PMID:20628086   PMID:20855565   PMID:21145461   PMID:21182205   PMID:21319273   PMID:21429623   PMID:21516116   PMID:21526344   PMID:21705670  
PMID:21873635   PMID:22479522   PMID:23296401   PMID:23376485   PMID:23533145   PMID:23602568   PMID:23690001   PMID:23715769   PMID:23777559   PMID:23895740   PMID:24167586   PMID:24623722  
PMID:25261976   PMID:25416956   PMID:25513803   PMID:25609649   PMID:25910212   PMID:25918162   PMID:25953740   PMID:26083030   PMID:26186194   PMID:26826316   PMID:26829325   PMID:27068509  
PMID:27197790   PMID:27271124   PMID:27705803   PMID:27804940   PMID:28301514   PMID:28514442   PMID:28675297   PMID:28977666   PMID:29117568   PMID:29222871   PMID:29509190   PMID:29863498  
PMID:29869155   PMID:30097533   PMID:30353968   PMID:30630053   PMID:30884312   PMID:31280863   PMID:31436131   PMID:31515488   PMID:31779197   PMID:31872472   PMID:31994214   PMID:32203420  
PMID:32235678   PMID:32296183   PMID:32554047   PMID:32707033   PMID:32798728   PMID:32921312   PMID:33514021   PMID:33567341   PMID:33729478   PMID:33961781   PMID:34099652   PMID:34383978  
PMID:34591612   PMID:35227662   PMID:35831895   PMID:36571249   PMID:37343697   PMID:37728985  


Genomics

Comparative Map Data
APOD
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh383195,568,705 - 195,583,940 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl3195,568,705 - 195,584,033 (-)EnsemblGRCh38hg38GRCh38
GRCh373195,295,576 - 195,310,811 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 363196,776,865 - 196,792,278 (-)NCBINCBI36Build 36hg18NCBI36
Celera3193,705,274 - 193,720,781 (-)NCBICelera
Cytogenetic Map3q29NCBI
HuRef3192,666,066 - 192,681,572 (-)NCBIHuRef
CHM1_13195,258,489 - 195,273,995 (-)NCBICHM1_1
T2T-CHM13v2.03198,275,776 - 198,291,015 (-)NCBIT2T-CHM13v2.0
Apod
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391631,115,010 - 31,133,626 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1631,115,010 - 31,133,626 (-)EnsemblGRCm39 Ensembl
GRCm381631,296,192 - 31,314,808 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1631,296,192 - 31,314,808 (-)EnsemblGRCm38mm10GRCm38
MGSCv371631,296,278 - 31,314,682 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361631,215,939 - 31,234,343 (-)NCBIMGSCv36mm8
Celera1631,811,354 - 31,812,738 (-)NCBICelera
Cytogenetic Map16B2NCBI
cM Map1621.41NCBI
Apod
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81182,936,216 - 82,957,264 (+)NCBIGRCr8
GRCr8 Ensembl1182,936,038 - 82,957,263 (+)EnsemblGRCr8 Ensembl
mRatBN7.21169,431,261 - 69,452,306 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1169,431,260 - 69,452,305 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1178,268,259 - 78,289,302 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01170,921,321 - 70,942,415 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01169,957,346 - 69,978,387 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01172,705,204 - 72,726,263 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1172,705,129 - 72,726,301 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01175,781,496 - 75,804,020 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1168,851,395 - 68,872,467 (+)NCBICelera
Cytogenetic Map11q22NCBI
Apod
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495542013,553,058 - 13,573,690 (+)EnsemblChiLan1.0
ChiLan1.0NW_00495542013,553,254 - 13,570,357 (+)NCBIChiLan1.0ChiLan1.0
APOD
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v22193,479,636 - 193,495,178 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan13193,484,335 - 193,499,805 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v03192,852,887 - 192,868,233 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.13203,152,476 - 203,167,888 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl3203,152,476 - 203,168,060 (-)Ensemblpanpan1.1panPan2
APOD
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.13330,490,149 - 30,504,804 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl3330,488,135 - 30,509,289 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha3330,513,383 - 30,531,252 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.03330,739,971 - 30,756,943 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl3330,737,959 - 30,803,155 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.13330,534,404 - 30,551,475 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.03330,570,143 - 30,588,341 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.03331,191,636 - 31,209,901 (+)NCBIUU_Cfam_GSD_1.0
Apod
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_024405602143,660,676 - 143,676,991 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936833259,660 - 277,246 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_004936833260,798 - 277,060 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
APOD
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl13132,514,949 - 132,562,599 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.113132,514,546 - 132,562,594 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.213142,076,180 - 142,096,088 (+)NCBISscrofa10.2Sscrofa10.2susScr3
APOD
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.11589,612,210 - 89,624,038 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl1589,612,040 - 89,624,012 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366604163,376,402 - 63,388,926 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Apod
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462473062,530,673 - 62,555,129 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462473062,535,005 - 62,552,405 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in APOD
21 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 3q27.2-29(chr3:185485849-198110178)x1 copy number loss See cases [RCV000051608] Chr3:185485849..198110178 [GRCh38]
Chr3:185203637..197837049 [GRCh37]
Chr3:186686331..199321446 [NCBI36]
Chr3:3q27.2-29
pathogenic
GRCh38/hg38 3q24-29(chr3:147521892-198096565)x3 copy number gain See cases [RCV000051725] Chr3:147521892..198096565 [GRCh38]
Chr3:147239679..197823436 [GRCh37]
Chr3:148722369..199307833 [NCBI36]
Chr3:3q24-29
pathogenic
GRCh38/hg38 3q25.31-29(chr3:157293378-198134727)x3 copy number gain See cases [RCV000051726] Chr3:157293378..198134727 [GRCh38]
Chr3:157011167..197861598 [GRCh37]
Chr3:158493861..199345995 [NCBI36]
Chr3:3q25.31-29
pathogenic
GRCh38/hg38 3q26.32-29(chr3:178411707-198110319)x3 copy number gain See cases [RCV000051736] Chr3:178411707..198110319 [GRCh38]
Chr3:178129495..197837190 [GRCh37]
Chr3:179612189..199321587 [NCBI36]
Chr3:3q26.32-29
pathogenic
GRCh38/hg38 3q27.2-29(chr3:185920880-198110319)x3 copy number gain See cases [RCV000051738] Chr3:185920880..198110319 [GRCh38]
Chr3:185638668..197837190 [GRCh37]
Chr3:187121362..199321587 [NCBI36]
Chr3:3q27.2-29
pathogenic
GRCh38/hg38 3q28-29(chr3:189265371-198110178)x3 copy number gain See cases [RCV000051739] Chr3:189265371..198110178 [GRCh38]
Chr3:188983160..197837049 [GRCh37]
Chr3:190465854..199321446 [NCBI36]
Chr3:3q28-29
pathogenic
GRCh38/hg38 3q28-29(chr3:190667663-198110178)x3 copy number gain See cases [RCV000051740] Chr3:190667663..198110178 [GRCh38]
Chr3:190385452..197837049 [GRCh37]
Chr3:191868146..199321446 [NCBI36]
Chr3:3q28-29
pathogenic
GRCh38/hg38 3q29(chr3:193917490-198110319)x3 copy number gain See cases [RCV000051741] Chr3:193917490..198110319 [GRCh38]
Chr3:193635279..197837190 [GRCh37]
Chr3:195117973..199321587 [NCBI36]
Chr3:3q29
pathogenic
GRCh38/hg38 3q22.3-29(chr3:137126982-198110178)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051723]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051723]|See cases [RCV000051723] Chr3:137126982..198110178 [GRCh38]
Chr3:136845824..197837049 [GRCh37]
Chr3:138328514..199321446 [NCBI36]
Chr3:3q22.3-29
pathogenic
NM_001647.3(APOD):c.334+239G>C single nucleotide variant Lung cancer [RCV000093443] Chr3:195571038 [GRCh38]
Chr3:195297909 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.3(APOD):c.124-2165C>G single nucleotide variant Lung cancer [RCV000093444] Chr3:195576136 [GRCh38]
Chr3:195303007 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.3(APOD):c.-34-1226G>T single nucleotide variant Lung cancer [RCV000093445] Chr3:195580721 [GRCh38]
Chr3:195307592 [GRCh37]
Chr3:3q29
uncertain significance
GRCh38/hg38 3q13.11-29(chr3:103426882-198110178)x3 copy number gain See cases [RCV000134948] Chr3:103426882..198110178 [GRCh38]
Chr3:103145726..197837049 [GRCh37]
Chr3:104628416..199321446 [NCBI36]
Chr3:3q13.11-29
pathogenic
GRCh38/hg38 3q29(chr3:195537179-195732718)x3 copy number gain See cases [RCV000135914] Chr3:195537179..195732718 [GRCh38]
Chr3:195263979..195459589 [GRCh37]
Chr3:196745268..196945260 [NCBI36]
Chr3:3q29
benign
GRCh38/hg38 3q26.2-29(chr3:168167568-198110178)x3 copy number gain See cases [RCV000137106] Chr3:168167568..198110178 [GRCh38]
Chr3:167885356..197837049 [GRCh37]
Chr3:169368050..199321446 [NCBI36]
Chr3:3q26.2-29
pathogenic
GRCh38/hg38 3q26.32-29(chr3:176439911-198118383)x3 copy number gain See cases [RCV000138009] Chr3:176439911..198118383 [GRCh38]
Chr3:176157699..197845254 [GRCh37]
Chr3:177640393..199329651 [NCBI36]
Chr3:3q26.32-29
pathogenic|likely benign
GRCh38/hg38 3q29(chr3:192752937-198118383)x3 copy number gain See cases [RCV000137827] Chr3:192752937..198118383 [GRCh38]
Chr3:192470726..197845254 [GRCh37]
Chr3:193953420..199329651 [NCBI36]
Chr3:3q29
pathogenic
GRCh38/hg38 3q29(chr3:194424496-198168758)x3 copy number gain See cases [RCV000051742] Chr3:194424496..198168758 [GRCh38]
Chr3:194145225..197895629 [GRCh37]
Chr3:195626514..199380026 [NCBI36]
Chr3:3q29
pathogenic
GRCh38/hg38 3q29(chr3:194338534-197693741)x1 copy number loss See cases [RCV000136517] Chr3:194338534..197693741 [GRCh38]
Chr3:194059263..197420612 [GRCh37]
Chr3:195540958..198905009 [NCBI36]
Chr3:3q29
pathogenic|uncertain significance
GRCh38/hg38 3q29(chr3:195147600-195711857)x3 copy number gain See cases [RCV000136583] Chr3:195147600..195711857 [GRCh38]
Chr3:194868329..195438728 [GRCh37]
Chr3:196349618..196924399 [NCBI36]
Chr3:3q29
uncertain significance
GRCh38/hg38 3q29(chr3:195537187-195736631)x3 copy number gain See cases [RCV000136843] Chr3:195537187..195736631 [GRCh38]
Chr3:195263987..195463502 [GRCh37]
Chr3:196745276..196949173 [NCBI36]
Chr3:3q29
benign
GRCh38/hg38 3q26.32-29(chr3:176168525-198118383)x3 copy number gain See cases [RCV000138662] Chr3:176168525..198118383 [GRCh38]
Chr3:175886313..197845254 [GRCh37]
Chr3:177369007..199329651 [NCBI36]
Chr3:3q26.32-29
pathogenic
GRCh38/hg38 3q29(chr3:194296197-198110198)x3 copy number gain See cases [RCV000138492] Chr3:194296197..198110198 [GRCh38]
Chr3:194013986..197837069 [GRCh37]
Chr3:195496680..199321466 [NCBI36]
Chr3:3q29
pathogenic
GRCh38/hg38 3q29(chr3:195537024-195730806)x3 copy number gain See cases [RCV000138633] Chr3:195537024..195730806 [GRCh38]
Chr3:195263824..195457677 [GRCh37]
Chr3:196745113..196943348 [NCBI36]
Chr3:3q29
likely benign
GRCh38/hg38 3q29(chr3:195537024-195730806)x1 copy number loss See cases [RCV000138634] Chr3:195537024..195730806 [GRCh38]
Chr3:195263824..195457677 [GRCh37]
Chr3:196745113..196943348 [NCBI36]
Chr3:3q29
likely benign
GRCh38/hg38 3q25.1-29(chr3:152100512-198118383)x3 copy number gain See cases [RCV000139435] Chr3:152100512..198118383 [GRCh38]
Chr3:151818301..197845254 [GRCh37]
Chr3:153300991..199329651 [NCBI36]
Chr3:3q25.1-29
pathogenic
GRCh38/hg38 3q25.31-29(chr3:156321878-198113452)x3 copy number gain See cases [RCV000140849] Chr3:156321878..198113452 [GRCh38]
Chr3:156039667..197840323 [GRCh37]
Chr3:157522361..199324720 [NCBI36]
Chr3:3q25.31-29
pathogenic
GRCh38/hg38 3q25.31-29(chr3:156118441-198125115)x3 copy number gain See cases [RCV000142310] Chr3:156118441..198125115 [GRCh38]
Chr3:155836230..197851986 [GRCh37]
Chr3:157318924..199336383 [NCBI36]
Chr3:3q25.31-29
pathogenic
GRCh38/hg38 3q26.1-29(chr3:166137209-198125115)x3 copy number gain See cases [RCV000143694] Chr3:166137209..198125115 [GRCh38]
Chr3:165854997..197851986 [GRCh37]
Chr3:167337691..199336383 [NCBI36]
Chr3:3q26.1-29
pathogenic
GRCh38/hg38 3q29(chr3:193704605-198125115)x3 copy number gain See cases [RCV000143501] Chr3:193704605..198125115 [GRCh38]
Chr3:193422394..197851986 [GRCh37]
Chr3:194905088..199336383 [NCBI36]
Chr3:3q29
pathogenic
GRCh37/hg19 3q25.32-29(chr3:158980631-197766890)x3 copy number gain See cases [RCV000447464] Chr3:158980631..197766890 [GRCh37]
Chr3:3q25.32-29
pathogenic
GRCh37/hg19 3q26.33-29(chr3:181911498-197851986)x4 copy number gain See cases [RCV000446732] Chr3:181911498..197851986 [GRCh37]
Chr3:3q26.33-29
pathogenic
GRCh37/hg19 3q25.2-29(chr3:152356847-197851986)x3 copy number gain See cases [RCV000448608] Chr3:152356847..197851986 [GRCh37]
Chr3:3q25.2-29
pathogenic
NM_001647.4(APOD):c.178C>T (p.Arg60Cys) single nucleotide variant not specified [RCV004296860] Chr3:195573917 [GRCh38]
Chr3:195300788 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986) copy number gain See cases [RCV000512358] Chr3:61892..197851986 [GRCh37]
Chr3:3p26.3-q29
pathogenic
GRCh37/hg19 3q26.33-29(chr3:182539234-197851986)x3 copy number gain not provided [RCV000682336] Chr3:182539234..197851986 [GRCh37]
Chr3:3q26.33-29
pathogenic
GRCh37/hg19 3q27.1-29(chr3:184003967-197851986)x3 copy number gain not provided [RCV000682339] Chr3:184003967..197851986 [GRCh37]
Chr3:3q27.1-29
pathogenic
GRCh37/hg19 3q28-29(chr3:191593619-197851986)x3 copy number gain not provided [RCV000682346] Chr3:191593619..197851986 [GRCh37]
Chr3:3q28-29
pathogenic
GRCh37/hg19 3q27.3-29(chr3:186374365-197851986)x3 copy number gain not provided [RCV000682341] Chr3:186374365..197851986 [GRCh37]
Chr3:3q27.3-29
pathogenic
GRCh37/hg19 3p26.3-q29(chr3:61495-197838262)x3 copy number gain not provided [RCV000742138] Chr3:61495..197838262 [GRCh37]
Chr3:3p26.3-q29
pathogenic
GRCh37/hg19 3p26.3-q29(chr3:60174-197948027)x3 copy number gain not provided [RCV000742133] Chr3:60174..197948027 [GRCh37]
Chr3:3p26.3-q29
pathogenic
GRCh37/hg19 3q27.3-29(chr3:186374671-197838262)x3 copy number gain not provided [RCV000743037] Chr3:186374671..197838262 [GRCh37]
Chr3:3q27.3-29
pathogenic
NM_001647.4(APOD):c.44T>C (p.Phe15Ser) single nucleotide variant APOD-related disorder [RCV003895753]|not provided [RCV000948671] Chr3:195579418 [GRCh38]
Chr3:195306289 [GRCh37]
Chr3:3q29
benign
NM_001647.4(APOD):c.165C>A (p.Thr55=) single nucleotide variant not provided [RCV000925461] Chr3:195573930 [GRCh38]
Chr3:195300801 [GRCh37]
Chr3:3q29
likely benign
GRCh37/hg19 3q29(chr3:195279196-196022437)x3 copy number gain not provided [RCV000846857] Chr3:195279196..196022437 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3q29(chr3:195279003-195718752)x3 copy number gain not provided [RCV001834344] Chr3:195279003..195718752 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3q29(chr3:194790394-197961930)x3 copy number gain Chromosome 3q29 microdeletion syndrome [RCV001801188] Chr3:194790394..197961930 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3q26.31-29(chr3:171558472-197871052)x3 copy number gain Isolated anorectal malformation [RCV002286610] Chr3:171558472..197871052 [GRCh37]
Chr3:3q26.31-29
likely pathogenic
GRCh37/hg19 3q29(chr3:195279004-195743958)x4 copy number gain not provided [RCV002473569] Chr3:195279004..195743958 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.142G>A (p.Glu48Lys) single nucleotide variant not specified [RCV004184894] Chr3:195573953 [GRCh38]
Chr3:195300824 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.85C>T (p.Pro29Ser) single nucleotide variant not specified [RCV004202811] Chr3:195579377 [GRCh38]
Chr3:195306248 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.304C>G (p.Pro102Ala) single nucleotide variant not specified [RCV004195306] Chr3:195571307 [GRCh38]
Chr3:195298178 [GRCh37]
Chr3:3q29
uncertain significance
Single allele duplication not provided [RCV003448704] Chr3:176412210..197847235 [GRCh37]
Chr3:3q26.32-29
pathogenic
NM_001647.4(APOD):c.226G>A (p.Val76Met) single nucleotide variant not provided [RCV003439098] Chr3:195573869 [GRCh38]
Chr3:195300740 [GRCh37]
Chr3:3q29
benign
Single allele duplication not provided [RCV003448680] Chr3:140154329..197847235 [GRCh37]
Chr3:3q23-29
pathogenic
GRCh37/hg19 3q26.33-29(chr3:179313373-197851444)x3 copy number gain See cases [RCV004442807] Chr3:179313373..197851444 [GRCh37]
Chr3:3q26.33-29
pathogenic
NM_001647.4(APOD):c.166T>G (p.Phe56Val) single nucleotide variant APOD-related disorder [RCV003941998] Chr3:195573929 [GRCh38]
Chr3:195300800 [GRCh37]
Chr3:3q29
benign
NM_001647.4(APOD):c.157C>T (p.Pro53Ser) single nucleotide variant not specified [RCV004837059] Chr3:195573938 [GRCh38]
Chr3:195300809 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.531G>A (p.Met177Ile) single nucleotide variant not specified [RCV004837049] Chr3:195568939 [GRCh38]
Chr3:195295810 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3p26.3-q29(chr3:61892-197851986)x3 copy number gain See cases [RCV000511055] Chr3:61892..197851986 [GRCh37]
Chr3:3p26.3-q29
pathogenic
GRCh37/hg19 3q28-29(chr3:187913567-197851986)x3 copy number gain not provided [RCV000682344] Chr3:187913567..197851986 [GRCh37]
Chr3:3q28-29
pathogenic
GRCh37/hg19 3q26.31-29(chr3:173281266-197838262)x3 copy number gain not provided [RCV000742968] Chr3:173281266..197838262 [GRCh37]
Chr3:3q26.31-29
pathogenic
GRCh37/hg19 3q28-29(chr3:189101446-197838262)x1 copy number loss not provided [RCV000743049] Chr3:189101446..197838262 [GRCh37]
Chr3:3q28-29
pathogenic
GRCh37/hg19 3q28-29(chr3:188386566-197838262)x3 copy number gain See cases [RCV000790566] Chr3:188386566..197838262 [GRCh37]
Chr3:3q28-29
pathogenic
GRCh37/hg19 3q28-29(chr3:189608636-197532175)x1 copy number loss 3q28q29 deletion syndrome [RCV001786535] Chr3:189608636..197532175 [GRCh37]
Chr3:3q28-29
pathogenic
GRCh37/hg19 3q29(chr3:195068028-197851986)x3 copy number gain not provided [RCV001259831] Chr3:195068028..197851986 [GRCh37]
Chr3:3q29
pathogenic
GRCh37/hg19 3q29(chr3:194498718-196196789)x1 copy number loss not provided [RCV001270643] Chr3:194498718..196196789 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3q28-29(chr3:191866466-197842171)x1 copy number loss not provided [RCV001795848] Chr3:191866466..197842171 [GRCh37]
Chr3:3q28-29
pathogenic
GRCh37/hg19 3q27.1-29(chr3:183498520-197851986)x3 copy number gain See cases [RCV002286344] Chr3:183498520..197851986 [GRCh37]
Chr3:3q27.1-29
pathogenic
NM_001647.4(APOD):c.559A>G (p.Lys187Glu) single nucleotide variant not specified [RCV004195495] Chr3:195568911 [GRCh38]
Chr3:195295782 [GRCh37]
Chr3:3q29
likely benign
NM_001647.4(APOD):c.31C>G (p.Leu11Val) single nucleotide variant not specified [RCV004099307] Chr3:195579431 [GRCh38]
Chr3:195306302 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.370G>A (p.Asp124Asn) single nucleotide variant not specified [RCV004238932] Chr3:195569100 [GRCh38]
Chr3:195295971 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.350C>T (p.Pro117Leu) single nucleotide variant not specified [RCV004255963] Chr3:195569120 [GRCh38]
Chr3:195295991 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3q29(chr3:195244842-195769200)x3 copy number gain not provided [RCV003484162] Chr3:195244842..195769200 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.74T>C (p.Leu25Pro) single nucleotide variant not specified [RCV004417830] Chr3:195579388 [GRCh38]
Chr3:195306259 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.160A>C (p.Thr54Pro) single nucleotide variant not specified [RCV004417828] Chr3:195573935 [GRCh38]
Chr3:195300806 [GRCh37]
Chr3:3q29
uncertain significance
NM_001647.4(APOD):c.383A>G (p.Tyr128Cys) single nucleotide variant APOD-related disorder [RCV003921882] Chr3:195569087 [GRCh38]
Chr3:195295958 [GRCh37]
Chr3:3q29
likely benign
NM_001647.4(APOD):c.274G>C (p.Gly92Arg) single nucleotide variant not specified [RCV004417829] Chr3:195571337 [GRCh38]
Chr3:195298208 [GRCh37]
Chr3:3q29
uncertain significance
GRCh37/hg19 3q29(chr3:195106447-197846145)x3 copy number gain not provided [RCV004577475] Chr3:195106447..197846145 [GRCh37]
Chr3:3q29
pathogenic
GRCh37/hg19 3q26.31-29(chr3:174764228-197851986)x3 copy number gain not provided [RCV004819300] Chr3:174764228..197851986 [GRCh37]
Chr3:3q26.31-29
pathogenic
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:1024
Count of miRNA genes:506
Interacting mature miRNAs:551
Transcripts:ENST00000343267, ENST00000421243, ENST00000453131, ENST00000458447, ENST00000463719
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCh38)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
597264803GWAS1360877_Hhigh density lipoprotein cholesterol measurement QTL GWAS1360877 (human)9e-09blood HDL cholesterol amount (VT:0000184)blood high density lipoprotein cholesterol level (CMO:0000052)3195572021195572022Human
597038393GWAS1134467_Hhigh density lipoprotein cholesterol measurement QTL GWAS1134467 (human)2e-08blood HDL cholesterol amount (VT:0000184)blood high density lipoprotein cholesterol level (CMO:0000052)3195572021195572022Human

Markers in Region
D3S1305  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh373195,310,991 - 195,311,194UniSTSGRCh37
GRCh373195,311,005 - 195,311,194UniSTSGRCh37
Build 363196,792,294 - 196,792,483RGDNCBI36
Celera3193,720,710 - 193,720,899RGD
Celera3193,720,696 - 193,720,899UniSTS
HuRef3192,681,501 - 192,681,690UniSTS
HuRef3192,681,487 - 192,681,690UniSTS
Marshfield Genetic Map3222.83RGD
Genethon Genetic Map3225.1UniSTS
TNG Radiation Hybrid Map3108349.0UniSTS
deCODE Assembly Map3217.6UniSTS
Stanford-G3 RH Map38607.0UniSTS
NCBI RH Map32087.5UniSTS
GeneMap99-G3 RH Map39077.0UniSTS
GDB:181196  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh373195,295,624 - 195,295,804UniSTSGRCh37
Build 363196,776,913 - 196,777,093RGDNCBI36
Celera3193,705,325 - 193,705,508RGD
Cytogenetic Map3q26.2-qterUniSTS
HuRef3192,666,117 - 192,666,301UniSTS
WI-18936  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh373195,295,629 - 195,295,903UniSTSGRCh37
Build 363196,776,918 - 196,777,192RGDNCBI36
Celera3193,705,330 - 193,705,607RGD
Cytogenetic Map3q26.2-qterUniSTS
HuRef3192,666,122 - 192,666,400UniSTS
GeneMap99-GB4 RH Map3726.38UniSTS
Whitehead-RH Map3879.6UniSTS
STS-W81076  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh373195,295,589 - 195,295,813UniSTSGRCh37
Build 363196,776,878 - 196,777,102RGDNCBI36
Celera3193,705,290 - 193,705,517RGD
Cytogenetic Map3q26.2-qterUniSTS
HuRef3192,666,082 - 192,666,310UniSTS
GeneMap99-GB4 RH Map3737.22UniSTS
STS-J02611  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh373195,295,748 - 195,295,963UniSTSGRCh37
GRCh373195,295,601 - 195,295,777UniSTSGRCh37
Build 363196,776,890 - 196,777,066RGDNCBI36
Celera3193,705,452 - 193,705,667UniSTS
Celera3193,705,302 - 193,705,481RGD
Cytogenetic Map3q26.2-qterUniSTS
HuRef3192,666,094 - 192,666,274UniSTS
HuRef3192,666,245 - 192,666,460UniSTS
TNG Radiation Hybrid Map3108338.0UniSTS
GeneMap99-GB4 RH Map3726.38UniSTS
RH69430  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh373195,295,749 - 195,295,894UniSTSGRCh37
Build 363196,777,038 - 196,777,183RGDNCBI36
Celera3193,705,453 - 193,705,598RGD
Cytogenetic Map3q26.2-qterUniSTS
HuRef3192,666,246 - 192,666,391UniSTS
GeneMap99-GB4 RH Map3726.48UniSTS
STS-J02611  
Human AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map3q26.2-qterUniSTS
TNG Radiation Hybrid Map3108338.0UniSTS
GeneMap99-GB4 RH Map3726.48UniSTS
D3S1305  
Human AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map3q26.2-qterUniSTS
Marshfield Genetic Map3222.83UniSTS
Genethon Genetic Map3225.1UniSTS
deCODE Assembly Map3217.6UniSTS
D3S1305  
Human AssemblyChrPosition (strand)SourceJBrowse
Cytogenetic Map3q26.2-qterUniSTS
TNG Radiation Hybrid Map3108349.0UniSTS
Stanford-G3 RH Map38607.0UniSTS
NCBI RH Map32087.5UniSTS
GeneMap99-G3 RH Map39077.0UniSTS


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
entire extraembryonic component
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
pharyngeal arch
renal system
reproductive system
respiratory system
sensory system
visual system
1204 2421 2788 2246 4869 1704 2273 6 608 1774 447 2188 7078 6296 46 3705 1 822 1704 1559 174 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NM_001647 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AB839003 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AC069213 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AH002605 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK294523 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AK312090 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC007402 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BQ008672 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BT019860 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BT019861 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BU195270 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BU727194 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH471052 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068275 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CR456838 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CR541773 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  DA892855 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  J02611 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  S80440 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Ensembl Acc Id: ENST00000343267   ⟹   ENSP00000345179
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl3195,568,705 - 195,583,940 (-)Ensembl
Ensembl Acc Id: ENST00000421243   ⟹   ENSP00000415235
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl3195,568,908 - 195,583,940 (-)Ensembl
Ensembl Acc Id: ENST00000453131   ⟹   ENSP00000393076
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl3195,569,022 - 195,583,940 (-)Ensembl
Ensembl Acc Id: ENST00000458447   ⟹   ENSP00000391597
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl3195,568,753 - 195,583,954 (-)Ensembl
Ensembl Acc Id: ENST00000463719
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl3195,570,591 - 195,584,033 (-)Ensembl
RefSeq Acc Id: NM_001647   ⟹   NP_001638
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh383195,568,705 - 195,583,940 (-)NCBI
GRCh373195,295,573 - 195,311,076 (-)ENTREZGENE
Build 363196,776,865 - 196,792,278 (-)NCBI Archive
HuRef3192,666,066 - 192,681,572 (-)ENTREZGENE
CHM1_13195,258,489 - 195,273,995 (-)NCBI
T2T-CHM13v2.03198,275,776 - 198,291,015 (-)NCBI
Sequence:
RefSeq Acc Id: NP_001638   ⟸   NM_001647
- Peptide Label: precursor
- UniProtKB: D3DNW6 (UniProtKB/Swiss-Prot),   B2R579 (UniProtKB/Swiss-Prot),   Q6IBG6 (UniProtKB/Swiss-Prot),   P05090 (UniProtKB/Swiss-Prot),   C9JF17 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSP00000393076   ⟸   ENST00000453131
Ensembl Acc Id: ENSP00000391597   ⟸   ENST00000458447
Ensembl Acc Id: ENSP00000415235   ⟸   ENST00000421243
Ensembl Acc Id: ENSP00000345179   ⟸   ENST00000343267
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P05090-F1-model_v2 AlphaFold P05090 1-189 view protein structure

Promoters
RGD ID:6866664
Promoter ID:EPDNEW_H6496
Type:initiation region
Name:APOD_1
Description:apolipoprotein D
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh383195,583,940 - 195,584,000EPDNEW
RGD ID:6851370
Promoter ID:EP73483
Type:initiation region
Name:HS_APOD
Description:Apolipoprotein D.
SO ACC ID:SO:0000170
Source:EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:NEDO full length human cDNA sequencing project.; Oligo-capping
Position:
Human AssemblyChrPosition (strand)Source
Build 363196,792,100 - 196,792,160EPD

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:612 AgrOrtholog
COSMIC APOD COSMIC
Ensembl Genes ENSG00000189058 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000343267 ENTREZGENE
  ENST00000343267.8 UniProtKB/Swiss-Prot
Gene3D-CATH 2.40.128.20 UniProtKB/Swiss-Prot
GTEx ENSG00000189058 GTEx
HGNC ID HGNC:612 ENTREZGENE
Human Proteome Map APOD Human Proteome Map
InterPro ApoD_vertbrte UniProtKB/Swiss-Prot
  ApolipopD UniProtKB/Swiss-Prot
  Calycin UniProtKB/Swiss-Prot
  Lipocalin_ApoD UniProtKB/Swiss-Prot
  Lipocalin_CS UniProtKB/Swiss-Prot
  Lipocln_cytosolic_FA-bd_dom UniProtKB/Swiss-Prot
KEGG Report hsa:347 UniProtKB/Swiss-Prot
NCBI Gene 347 ENTREZGENE
OMIM 107740 OMIM
PANTHER APOLIPOPROTEIN D UniProtKB/Swiss-Prot
  APOLIPOPROTEIN D UniProtKB/Swiss-Prot
Pfam Lipocalin_2 UniProtKB/Swiss-Prot
PharmGKB PA24900 PharmGKB
PIRSF Lipocalin_ApoD UniProtKB/Swiss-Prot
PRINTS APODVERTBRTE UniProtKB/Swiss-Prot
  APOLIPOPROTD UniProtKB/Swiss-Prot
  LIPOCALIN UniProtKB/Swiss-Prot
PROSITE LIPOCALIN UniProtKB/Swiss-Prot
Superfamily-SCOP SSF50814 UniProtKB/Swiss-Prot
UniProt APOD_HUMAN UniProtKB/Swiss-Prot
  B2R579 ENTREZGENE
  C9JF17 ENTREZGENE, UniProtKB/TrEMBL
  C9JX71_HUMAN UniProtKB/TrEMBL
  D3DNW6 ENTREZGENE
  F8WBT9_HUMAN UniProtKB/TrEMBL
  P05090 ENTREZGENE
  Q6IBG6 ENTREZGENE
UniProt Secondary B2R579 UniProtKB/Swiss-Prot
  D3DNW6 UniProtKB/Swiss-Prot
  Q6IBG6 UniProtKB/Swiss-Prot